232 related articles for article (PubMed ID: 32067500)
1. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
Abdeltawab H; Svirskis D; Sharma M
Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
[No Abstract] [Full Text] [Related]
2. Injectable thermosensitive gelling delivery system for the sustained release of lidocaine.
Svirskis D; Chandramouli K; Bhusal P; Wu Z; Alphonso J; Chow J; Patel D; Ramakrishna R; Yeo SJ; Stowers R; Hill A; Munro J; Young SW; Sharma M
Ther Deliv; 2016 Jun; 7(6):359-68. PubMed ID: 27250538
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.
Soliman KA; Ullah K; Shah A; Jones DS; Singh TRR
Drug Discov Today; 2019 Aug; 24(8):1575-1586. PubMed ID: 31175956
[TBL] [Abstract][Full Text] [Related]
4. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
Liu Y; Zhu YY; Wei G; Lu WY
Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
[TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo characterisation of an in situ gelling formulation for sustained lidocaine release with potential use following knee arthroplasty.
Sharma M; Chandramouli K; Curley L; Pontre B; Reilly K; Munro J; Hill A; Young S; Svirskis D
Drug Deliv Transl Res; 2018 Jun; 8(3):820-829. PubMed ID: 29411295
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
[TBL] [Abstract][Full Text] [Related]
7. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
8. In situ gelling system for sustained intraarticular delivery of bupivacaine and ketorolac in sheep.
Abdeltawab H; Bolam SM; Jaiswal JK; McGlashan SR; Young SW; Hill A; Svirskis D; Sharma M
Eur J Pharm Biopharm; 2022 May; 174():35-46. PubMed ID: 35364255
[TBL] [Abstract][Full Text] [Related]
9. Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407.
Bhowmik M; Kumari P; Sarkar G; Bain MK; Bhowmick B; Mollick MM; Mondal D; Maity D; Rana D; Bhattacharjee D; Chattopadhyay D
Int J Biol Macromol; 2013 Nov; 62():117-23. PubMed ID: 23988556
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
[TBL] [Abstract][Full Text] [Related]
11. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
12. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
Cao F; Zhang X; Ping Q
Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
14. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
[TBL] [Abstract][Full Text] [Related]
15. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
[TBL] [Abstract][Full Text] [Related]
16. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
Altuntaş E; Yener G
AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
[TBL] [Abstract][Full Text] [Related]
17. Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking Cessation.
Hulambukie E; Abdeltawab H; Duarah S; Svirskis D; Sharma M
Gels; 2022 Feb; 8(2):. PubMed ID: 35200495
[TBL] [Abstract][Full Text] [Related]
18. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
Ma WD; Xu H; Nie SF; Pan WS
Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
[TBL] [Abstract][Full Text] [Related]
19. Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.
Querobino SM; de Faria NC; Vigato AA; da Silva BGM; Machado IP; Costa MS; Costa FN; de Araujo DR; Alberto-Silva C
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1350-1361. PubMed ID: 30889669
[TBL] [Abstract][Full Text] [Related]
20. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
